270 related articles for article (PubMed ID: 22393080)
21. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
[TBL] [Abstract][Full Text] [Related]
22. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
[TBL] [Abstract][Full Text] [Related]
23. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines.
Bossi G; Lanzarini L; Laudisa ML; Klersy C; Raisaro A; Aricò M
Med Pediatr Oncol; 2001 Jun; 36(6):593-600. PubMed ID: 11344489
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.
Dietz AC; Sivanandam S; Konety S; Kaufman CL; Gage RM; Kelly AS; Neglia JP; Mulrooney DA
J Cancer Surviv; 2014 Jun; 8(2):183-9. PubMed ID: 24317971
[TBL] [Abstract][Full Text] [Related]
25. The utility of NT-proBNP and various echocardiographic methods in the determination of doxorubicin induced subclinical late cardiotoxicity.
Yildirim A; Tunaoglu FS; Kambur K; Pinarli FG
Kardiol Pol; 2013; 71(1):40-6. PubMed ID: 23348532
[TBL] [Abstract][Full Text] [Related]
26. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M
J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
[TBL] [Abstract][Full Text] [Related]
27. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
[TBL] [Abstract][Full Text] [Related]
28. Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for the detection of subclinical cardiotoxic effects of treatment with anthracyclines.
Kapusta L; Thijssen JM; Groot-Loonen J; van Druten JA; Daniëls O
Ultrasound Med Biol; 2001 Dec; 27(12):1605-14. PubMed ID: 11839405
[TBL] [Abstract][Full Text] [Related]
29. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
[TBL] [Abstract][Full Text] [Related]
30. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
[TBL] [Abstract][Full Text] [Related]
31. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
Lanzarini L; Bossi G; Laudisa ML; Klersy C; Aricò M
Am Heart J; 2000 Aug; 140(2):315-23. PubMed ID: 10925349
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy-associated cardiomyopathy in survivors of childhood cancer.
Hines MR; Mulrooney DA; Hudson MM; Ness KK; Green DM; Howard SC; Krasin M; Metzger ML
J Cancer Surviv; 2016 Feb; 10(1):113-21. PubMed ID: 26044903
[TBL] [Abstract][Full Text] [Related]
33. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
34. Two- and three-dimensional myocardial strain imaging in the interrogation of sex differences in cardiac mechanics of long-term survivors of childhood cancers.
Li VW; Liu AP; So EK; Ho KK; Yau JP; Cheuk DK; Cheung YF
Int J Cardiovasc Imaging; 2019 Jun; 35(6):999-1007. PubMed ID: 30848401
[TBL] [Abstract][Full Text] [Related]
35. Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.
Ylänen K; Eerola A; Vettenranta K; Poutanen T
Eur J Pediatr; 2016 Oct; 175(10):1379-86. PubMed ID: 27620626
[TBL] [Abstract][Full Text] [Related]
36. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion.
Yildirim A; Sedef Tunaoglu F; Pinarli FG; Ilhan M; Oguz A; Karadeniz C; Olguntürk R; Oguz D; Kula S
Eur J Echocardiogr; 2010 Dec; 11(10):814-22. PubMed ID: 20562426
[TBL] [Abstract][Full Text] [Related]
37. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.
Song FY; Shi J; Guo Y; Zhang CJ; Xu YC; Zhang QL; Shu XH; Cheng LL
Int J Cardiovasc Imaging; 2017 Jun; 33(6):857-868. PubMed ID: 28255826
[TBL] [Abstract][Full Text] [Related]
38. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.
Brouwer CA; Postma A; Vonk JM; Zwart N; van den Berg MP; Bink-Boelkens MT; Dolsma WV; Smit AJ; de Vries EG; Tissing WJ; Gietema JA
Eur J Cancer; 2011 Nov; 47(16):2453-62. PubMed ID: 21696947
[TBL] [Abstract][Full Text] [Related]
39. NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.
Zidan A; Sherief LM; El-sheikh A; Saleh SH; Shahbah DA; Kamal NM; Sherbiny HS; Ahmad H
Dis Markers; 2015; 2015():513219. PubMed ID: 25960594
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]